{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:19:07Z","timestamp":1785860347392,"version":"3.56.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1097\/01.fjc.0000211745.70831.75","type":"journal-article","created":{"date-parts":[[2006,5,8]],"date-time":"2006-05-08T04:10:58Z","timestamp":1147061458000},"page":"521-530","source":"Crossref","is-referenced-by-count":8,"title":["3-HMG-Coenzyme A Reductase Inhibition and Extracellular Matrix Gene Expression in the Pressure-Overloaded Rat Heart"],"prefix":"10.1097","volume":"47","author":[{"given":"Georgina M.","family":"Cirrincione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin O.","family":"Boluyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Seok","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry E.","family":"Bleske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210208","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000070669","article-title":"Rosuvastatin-A Highly Effective New 3- hydroxy-3-methylglutaryl Coenzyme A reductase inhibitor: review of clinical trial data at 10\u201340\u2009mg doses in dyslipidemic patients","volume":"99","author":"Schuster","year":"2003","journal-title":"Cardiology"},{"key":"R2-4-20210208","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R3-4-20210208","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.ATV.20.1.61","article-title":"Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation","volume":"20","author":"Wagner","year":"2000","journal-title":"Arterioscler Thromb Vasc Bio"},{"key":"R4-4-20210208","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"R5-4-20210208","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.bjp.0704070","article-title":"A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid","volume":"133","author":"Stalker","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R6-4-20210208","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/hc3401.095946","article-title":"Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction","volume":"104","author":"Bauersachs","year":"2001","journal-title":"Circulation"},{"key":"R7-4-20210208","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/hc0702.104164","article-title":"Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction","volume":"105","author":"Hayashidani","year":"2002","journal-title":"Circulation"},{"key":"R8-4-20210208","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/hc3001.092039","article-title":"Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3methylglutaryl coenzyme A reductase inhibitor","volume":"104","author":"Dechend","year":"2001","journal-title":"Circulation"},{"key":"R9-4-20210208","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0735-1097(03)00926-4","article-title":"Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models","volume":"42","author":"Susic","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R10-4-20210208","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1172\/JCI200113131","article-title":"HMG-CoA reductase inhibitor mobilizes bone marrow\u2013derived endothelial progenitor cells","volume":"108","author":"Llevadot","year":"2001","journal-title":"J Clin Invest"},{"key":"R11-4-20210208","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"key":"R12-4-20210208","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0008-6363(00)00043-2","article-title":"Bing OHL: Matrix gene expression and decompensated heart failure: the aged SHR model","volume":"46","author":"Boluyt","year":"2000","journal-title":"Cardiovasc Res"},{"key":"R13-4-20210208","first-page":"107","article-title":"Myocardial fibrosis: role of angiotensin II and aldosterone","volume":"88","author":"Weber","year":"1993","journal-title":"Bas Res Cardiol"},{"key":"R14-4-20210208","first-page":"H1861","article-title":"Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen","volume":"262","author":"Villarreal","year":"1992","journal-title":"Am J Physiol"},{"key":"R15-4-20210208","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1681\/ASN.V11180","article-title":"Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells","volume":"11","author":"Kim","year":"2000","journal-title":"J Am Soc Neph"},{"key":"R16-4-20210208","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1440-1681.1999.03165.x","article-title":"Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis","volume":"26","author":"Luo","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R17-4-20210208","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/B:CARD.0000041245.61136.56","article-title":"The mTOR\/p70(S6\u2009K) Signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo","volume":"18","author":"Boluyt","year":"2004","journal-title":"Cardiovasc Drugs Ther"},{"key":"R18-4-20210208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.RES.75.1.23","article-title":"Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components","volume":"75","author":"Boluyt","year":"1994","journal-title":"Circ Res"},{"key":"R19-4-20210208","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.RES.67.4.787","article-title":"Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium.","volume":"67","author":"Chapman","year":"1990","journal-title":"Circ Res"},{"key":"R20-4-20210208","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1073\/pnas.85.2.339","article-title":"Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload","volume":"85","author":"Izumo","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-4-20210208","doi-asserted-by":"crossref","first-page":"B28","DOI":"10.1016\/S0002-9149(01)01454-0","article-title":"Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"87","author":"McTaggart","year":"2001","journal-title":"Am J Cardiol"},{"key":"R22-4-20210208","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cardiores.2005.02.008","article-title":"Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts","volume":"66","author":"Di Napoli","year":"2005","journal-title":"Cardiovasc Res"},{"key":"R23-4-20210208","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.103.1.113","article-title":"Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance","volume":"103","author":"Feron","year":"2001","journal-title":"Circulation"},{"key":"R24-4-20210208","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0735-1097(02)02115-0","article-title":"Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor","volume":"40","author":"Jones","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R25-4-20210208","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00005344-200304000-00019","article-title":"Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats","volume":"41","author":"Ikeda","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"R26-4-20210208","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.0000034047.70205.97","article-title":"Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation","volume":"106","author":"Indolfi","year":"2002","journal-title":"Circulation"},{"key":"R27-4-20210208","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.yjmcc.2004.06.019","article-title":"Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis","volume":"37","author":"Chen","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"R28-4-20210208","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1054\/jcaf.2002.129259","article-title":"Extracellular degradative pathways in myocardial remodeling and progression to heart failure","volume":"8","author":"Spinale","year":"2002","journal-title":"J Card Fail"},{"key":"R29-4-20210208","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0008-6363(02)00792-7","article-title":"Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation","volume":"57","author":"Nishikawa","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R30-4-20210208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0735-1097(03)00578-3","article-title":"Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat","volume":"42","author":"Boixel","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R31-4-20210208","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.HYP.36.3.325","article-title":"Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells","volume":"36","author":"Ikeda","year":"2000","journal-title":"Hypertension"},{"key":"R32-4-20210208","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/00005344-200212000-00012","article-title":"Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy","volume":"40","author":"Ogata","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"R33-4-20210208","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/07853890310001294","article-title":"A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms","volume":"35","author":"Nakagami","year":"2003","journal-title":"Ann Med"},{"key":"R34-4-20210208","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.0000136088.18960.E6","article-title":"Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism","volume":"110","author":"Ito","year":"2004","journal-title":"Circulation"},{"key":"R35-4-20210208","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors","author":"Takemoto","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00128360-200604000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:22:59Z","timestamp":1785856979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200604000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fjc.0000211745.70831.75","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}